The Kerendia® self-guided learning platform offers an engaging journey, consisting of brief chapters that encapsulate how Kerendia® can benefit your patients with CKD associated with T2D.1
Personalize your journey
The initial section presents various patient profiles that you can select based on their relevance to your clinical practice. Your selection will determine the learning journey with the topics tailored to the profile of your choice.
Complete at your
own pace
Dive into the topics of practical relevance that you can study based on your individual interests. Stop the journey at any time and resume later at the point you last left off.
Engage while you learn
The digestible clinically-relevant content includes interactive features, such as surveys and gamifications, to help you easily navigate through the content.
In addition, the learning platform also offers the opportunity to get in touch with the Kerendia® expert team if there are still questions that go beyond the topics addressed here.
Abbreviations:
CKD=chronic kidney disease; T2D=type 2 diabetes.
Reference:
- Kerendia® European Summary of Product Characteristics (SmPC); February 2023. Return to content
© 2025 Bayer SG
This website was created by Bayer
and is intended to provide information to
healthcare professionals in Singapore only.
PP-KER-SG-0166-1 (01/25)
